Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon May 04, 2021 9:02am
99 Views
Post# 33122136

RE:RE:Stop Talking and Start Doing

RE:RE:Stop Talking and Start DoingYou need to understand the relationship between academia and industry. 

Ceapro sponors research to get the subsidized research they need done. The universities need to publish papers so the professors can attract research funds (govt and private). It's a symbiotic relationship. In addition have you noticed the PhD students that end up working at Ceapro? They get experienced staff who spents years working on PGX projects.

Lastly, yes, it is easier to publish and to present papers than to ink a deal.

I would believer that as the reserach is advanced, and we have the Edmonton plant and Germany plants setting up for commercial production we get that much closer to a deal.


hoffbag wrote: Minty nails it.

There is no time for that real business building heavy lifting.  Have to get that presentation to academia done on our exciting process developments and then have to get a fantastic research study kicked off so we can write more papers.........

I can picture the gang sipping coffee chatting about this cool IDEA on how they can infuse lavendar essence into AVN's for the ice cream market.....BUT shouldnt you be calling customers to find out what they are working on and get on their development programs....Ya, ya good idea, we should do that....oh wow, I just had an IDEA, that if we used PGX with mushrooms.....
 
Of course the response will be that they are on top of it and are working on this and that, whole list of exciting things for 2021.....but at the end of the day its RESULTS THAT COUNT.  I didnt see a revenue number attached to any of them.  Since 2018 revenues have grown by $3.5million.  Really, what earth shattering, ground breaking (or exciting and fantastic) business do we have here? 

Signed a shareholder.



<< Previous
Bullboard Posts
Next >>